Browsing by Author "Benveniste S."

Now showing 1 - 6 of 6
  • No Thumbnail Available
    Item
    Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1)
    (AME Publishing Company, 2019) Bousquet J.; Pham-Thi N.; Bedbrook A.; Agache I.; Annesi-Maesano I.; Ansotegui I.; Anto J.M.; Bachert C.; Benveniste S.; Bewick M.; Billo N.; Bosnic-Anticevich S.; Bosse I.; Brusselle G.; Calderon M.A.; Canonica G.W.; Caraballo L.; Cardona V.; Carriazo A.M.; Cash E.; Cecchi L.; Chu D.K.; Colgan E.; Costa E.; Cruz A.A.; Czarlewski W.; Durham S.; Ebisawa M.; Erhola M.; Fauquert J.-L.; Fokkens W.J.; Fonseca J.A.; Guldemond N.; Iinuma T.; Illario M.; Klimek L.; Kuna P.; Kvedariene V.; Larenas-Linneman D.; Laune D.; Le L.T.T.; Lourenço O.; Malva J.O.; Marien G.; Menditto E.; Mullol J.; Münter L.; Okamoto Y.; Onorato G.L.; Papadopoulos N.G.; Perala M.; Pfaar O.; Phillips A.; Phillips J.; Pinnock H.; Portejoie F.; Quinones-Delgado P.; Rolland C.; Rodts U.; Samolinski B.; Sanchez-Borges M.; Schünemann H.J.; Shamji M.; Somekh D.; Togias A.; Toppila-Salmi S.; Tsiligianni I.; Usmani O.; Walker S.; Wallace D.; Valiulis A.; Van Der Kleij R.; Ventura M.T.; Williams S.; Yorgancioglu A.; Zuberbier T.
    [No abstract available]
  • No Thumbnail Available
    Item
    Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases
    (BioMed Central Ltd., 2019) Bousquet J.J.; Schünemann H.J.; Togias A.; Erhola M.; Hellings P.W.; Zuberbier T.; Agache I.; Ansotegui I.J.; Anto J.M.; Bachert C.; Becker S.; Bedolla-Barajas M.; Bewick M.; Bosnic-Anticevich S.; Bosse I.; Boulet L.P.; Bourrez J.M.; Brusselle G.; Chavannes N.; Costa E.; Cruz A.A.; Czarlewski W.; Fokkens W.J.; Fonseca J.A.; Gaga M.; Haahtela T.; Illario M.; Klimek L.; Kuna P.; Kvedariene V.; Le L.T.T.; Larenas-Linnemann D.; Laune D.; Lourenço O.M.; Menditto E.; Mullol J.; Okamoto Y.; Papadopoulos N.; Pham-Thi N.; Picard R.; Pinnock H.; Roche N.; Roller-Wirnsberger R.E.; Rolland C.; Samolinski B.; Sheikh A.; Toppila-Salmi S.; Tsiligianni I.; Valiulis A.; Valovirta E.; Vasankari T.; Ventura M.-T.; Walker S.; Williams S.; Akdis C.A.; Annesi-Maesano I.; Arnavielhe S.; Basagana X.; Bateman E.; Bedbrook A.; Bennoor K.S.; Benveniste S.; Bergmann K.C.; Bialek S.; Billo N.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Bonini M.; Bonniaud P.; Bouchard J.; Briedis V.; Brightling C.E.; Brozek J.; Buhl R.; Buonaiuto R.; Canonica G.W.; Cardona V.; Carriazo A.M.; Carr W.; Cartier C.; Casale T.; Cecchi L.; Cepeda Sarabia A.M.; Chkhartishvili E.; Chu D.K.; Cingi C.; Colgan E.; De Sousa J.C.; Courbis A.L.; Custovic A.; Cvetkosvki B.; Damato G.; Da Silva J.; Dantas C.; Dokic D.; Dauvilliers Y.; Dedeu A.; De Feo G.; Devillier P.; Di Capua S.; Dykewickz M.; Dubakiene R.; Ebisawa M.; El-Gamal Y.; Eller E.; Emuzyte R.; Farrell J.; Fink-Wagner A.; Fiocchi A.; Fontaine J.F.; Gemicioǧlu B.; Schmid-Grendelmeir P.; Gamkrelidze A.; Garcia-Aymerich J.; Gomez M.; Diaz S.G.; Gotua M.; Guldemond N.A.; Guzmán M.-A.; Hajjam J.; O'Hourihane J.B.; Humbert M.; Iaccarino G.; Ierodiakonou D.; Ivancevich J.C.; Joos G.; Jung K.-S.; Jutel M.; Kaidashev I.; Kalayci O.; Kardas P.; Keil T.; Khaitov M.; Khaltaev N.; Kleine-Tebbe J.; Kowalski M.L.; Kritikos V.; Kull I.; Leonardini L.; Lieberman P.; Lipworth B.; Lodrup Carlsen K.C.; Loureiro C.C.; Louis R.; Mair A.; Marien G.; Mahboub B.; Malva J.; Manning P.; De Manuel Keenoy E.; Marshall G.D.; Masjedi M.R.; Maspero J.F.; Mathieu-Dupas E.; Matricardi P.M.; Melén E.; Melo-Gomes E.; Meltzer E.O.; Mercier J.; Miculinic N.; Mihaltan F.; Milenkovic B.; Moda G.; Mogica-Martinez M.-D.; Mohammad Y.; Montefort S.; Monti R.; Morais-Almeida M.; Mösges R.; Münter L.; Muraro A.; Murray R.; Naclerio R.; Napoli L.; Namazova-Baranova L.; Neffen H.; Nekam K.; Neou A.; Novellino E.; Nyembue D.; O'Hehir R.; Ohta K.; Okubo K.; Onorato G.; Ouedraogo S.; Pali-Schöll I.; Palkonen S.; Panzner P.; Park H.-S.; Pépin J.-L.; Pereira A.-M.; Pfaar O.; Paulino E.; Phillips J.; Plavec D.; Popov T.A.; Portejoie F.; Price D.; Prokopakis E.P.; Pugin B.; Raciborski F.; Rajabian-Söderlund R.; Reitsma S.; Rodo X.; Romano A.; Rosario N.; Rottem M.; Ryan D.; Salimäki J.; Sanchez-Borges M.M.; Sisul J.-C.; Solé D.; Somekh D.; Sooronbaev T.; Sova M.; Spranger O.; Stellato C.; Stelmach R.; Ulrik C.S.; Thibaudon M.; To T.; Todo-Bom A.; Tomazic P.V.; Valero A.A.; Valenta R.; Valentin-Rostan M.; Van Der Kleij R.; Vandenplas O.; Vezzani G.; Viart F.; Viegi G.; Wallace D.; Wagenmann M.; Wang D.Y.; Waserman S.; Wickman M.; Williams D.M.; Wong G.; Wroczynski P.; Yiallouros P.K.; Yorgancioglu A.; Yusuf O.M.; Zar H.J.; Zeng S.; Zernotti M.; Zhang L.; Zhong N.S.; Zidarn M.
    Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhi-nitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement. © The Author(s) 2019.
  • No Thumbnail Available
    Item
    Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)
    (AME Publishing Company, 2019) Bousquet J.; Pham-Thi N.; Bedbrook A.; Agache I.; Annesi-Maesano I.; Ansotegui I.; Anto J.M.; Bachert C.; Benveniste S.; Bewick M.; Billo N.; Bosnic-Anticevich S.; Bosse I.; Brusselle G.; Calderon M.A.; Canonica G.W.; Caraballo L.; Cardona V.; Carriazo A.M.; Cash E.; Cecchi L.; Chu D.K.; Colgan E.; Costa E.; Cruz A.A.; Czarlewski W.; Durham S.; Ebisawa M.; Erhola M.; Fauquert J.-L.; Fokkens W.J.; Fonseca J.A.; Guldemond N.; Iinuma T.; Illario M.; Klimek L.; Kuna P.; Kvedariene V.; Larenas-Linneman D.; Laune D.; Le L.T.T.; Lourenço O.; Malva J.O.; Marien G.; Menditto E.; Mullol J.; Münter L.; Okamoto Y.; Onorato G.L.; Papadopoulos N.G.; Perala M.; Pfaar O.; Phillips A.; Phillips J.; Pinnock H.; Portejoie F.; Quinones-Delgado P.; Rolland C.; Rodts U.; Samolinski B.; Sanchez-Borges M.; Schünemann H.J.; Shamji M.; Somekh D.; Togias A.; Toppila-Salmi S.; Tsiligianni I.; Usmani O.; Walker S.; Wallace D.; Valiulis A.; Van der Kleij R.; Ventura M.T.; Williams S.; Yorgancioglu A.; Zuberbier T.
    [No abstract available]
  • No Thumbnail Available
    Item
    Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing
    (Korean Academy of Asthma, Allergy and Clinical Immunology, 2020) Bousquet J.; Farrell J.; Onorato G.L.; Bedbrook A.; Czarlewski W.; Micheli Y.; Arnavielhe S.; Illario M.; Ansotegui I.J.; Anto J.M.; Bachert C.; Basagaña X.; Bédard A.; Benveniste S.; Bergmann K.C.; Bewick M.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Bosnic-Anticevich S.; Bosse I.; Braido F.; Brussino L.; Camuzat T.; Canonica G.W.; Cardona V.; Carreiro Martins P.; Cecchi L.; Chavannes N.H.; Chu D.K.; Correia da Sousa J.; Costa D.J.; Costa E.; Cruz A.A.; da Silva J.; Devillier P.; de Feo G.; de Vries G.; Dray G.; Ebisawa M.; Erhola M.; Fauquert J.L.; Fokkens W.J.; Fonseca J.; Fontaine J.M.; Gemicioğlu B.; Haahtela T.; Heffler E.; Hellings P.W.; Ivancevich J.C.; Jassem E.; Jutel M.; Kaidashev I.; Kalayci O.; Klimek L.; Kowalski M.L.; Kull I.; Kuna P.; Kvedariene V.; la Grutta S.; Laune D.; Larenas-Linnemann D.; Ierodiakonou D.; Le L.T.T.; Lourenço O.; Makris M.; Menditto E.; Monti R.; Morais-Almeida M.; Münter L.; Muraro A.; Murray R.; Maurer M.; Melén E.; Mösges R.; Mullol J.; Niedoszytko M.; O'Hehir R.E.; Okamoto Y.; Papadopoulos N.G.; Passalacqua G.; Patella V.; Pereira A.M.; Pfaar O.; Pham-Thi N.; Portejoie F.; Price D.; Prokopakis E.P.; Psarros F.; Raciborski F.; Regateiro F.; Reitsma S.; Roche N.; Rolland C.; Ryan D.; Samolinski B.; Sastre J.; Scadding G.K.; Schmid-Grendelmeier P.; Schünemann H.J.; Shamji M.; Sheikh A.; Stellato C.; Suppli-Ulrik C.; Somekh D.; Sova M.; Todo Bom A.; Tomazic P.V.; Toppila-Salmi S.; Triggiani M.; Tsiligianni I.; Valero A.; Valiulis A.; Valovirta E.; van Eerd M.; Vasankari T.; Ventura M.T.; Wallace D.; Waserman S.; Yorgancioglu A.; Zidarn M.; Zuberbier T.
    The reference sites of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) were renewed in 2019. The DG Santé good practice Mobile Airways Sentinel networK was reviewed to meet the objectives of the EIP on AHA. It included 1) Management of care process, 2) Blueprint of digital transformation, 3) EIP on AHA, innovation to market, 4) Community for monitoring and assessment framework, 5) Political, organizational, technological and financial readiness, 6) Contributing to European co-operation and transferability, 7) Delivering evidence of impact against the triple win approach, 8) Contribution to the European Digital Transformation of Health and Care and 9) scale of demonstration and deployment of innovation. © 2020 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:// creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • No Thumbnail Available
    Item
    ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
    (John Wiley and Sons Inc, 2021) Bousquet J.; Anto J.M.; Bachert C.; Haahtela T.; Zuberbier T.; Czarlewski W.; Bedbrook A.; Bosnic-Anticevich S.; Walter Canonica G.; Cardona V.; Costa E.; Cruz A.A.; Erhola M.; Fokkens W.J.; Fonseca J.A.; Illario M.; Ivancevich J.-C.; Jutel M.; Klimek L.; Kuna P.; Kvedariene V.; Le L.T.T.; Larenas-Linnemann D.E.; Laune D.; Lourenço O.M.; Melén E.; Mullol J.; Niedoszytko M.; Odemyr M.; Okamoto Y.; Papadopoulos N.G.; Patella V.; Pfaar O.; Pham-Thi N.; Rolland C.; Samolinski B.; Sheikh A.; Sofiev M.; Suppli Ulrik C.; Todo-Bom A.; Tomazic P.-V.; Toppila-Salmi S.; Tsiligianni I.; Valiulis A.; Valovirta E.; Ventura M.-T.; Walker S.; Williams S.; Yorgancioglu A.; Agache I.; Akdis C.A.; Almeida R.; Ansotegui I.J.; Annesi-Maesano I.; Arnavielhe S.; Basagaña X.; D. Bateman E.; Bédard A.; Bedolla-Barajas M.; Becker S.; Bennoor K.S.; Benveniste S.; Bergmann K.C.; Bewick M.; Bialek S.; E. Billo N.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Bonini M.; Bonniaud P.; Bosse I.; Bouchard J.; Boulet L.-P.; Bourret R.; Boussery K.; Braido F.; Briedis V.; Briggs A.; Brightling C.E.; Brozek J.; Brusselle G.; Brussino L.; Buhl R.; Buonaiuto R.; Calderon M.A.; Camargos P.; Camuzat T.; Caraballo L.; Carriazo A.-M.; Carr W.; Cartier C.; Casale T.; Cecchi L.; Cepeda Sarabia A.M.; H. Chavannes N.; Chkhartishvili E.; Chu D.K.; Cingi C.; Correia de Sousa J.; Costa D.J.; Courbis A.-L.; Custovic A.; Cvetkosvki B.; D'Amato G.; da Silva J.; Dantas C.; Dokic D.; Dauvilliers Y.; De Feo G.; De Vries G.; Devillier P.; Di Capua S.; Dray G.; Dubakiene R.; Durham S.R.; Dykewicz M.; Ebisawa M.; Gaga M.; El-Gamal Y.; Heffler E.; Emuzyte R.; Farrell J.; Fauquert J.-L.; Fiocchi A.; Fink-Wagner A.; Fontaine J.-F.; Fuentes Perez J.M.; Gemicioğlu B.; Gamkrelidze A.; Garcia-Aymerich J.; Gevaert P.; Gomez R.M.; González Diaz S.; Gotua M.; Guldemond N.A.; Guzmán M.-A.; Hajjam J.; Huerta Villalobos Y.R.; Humbert M.; Iaccarino G.; Ierodiakonou D.; Iinuma T.; Jassem E.; Joos G.; Jung K.-S.; Kaidashev I.; Kalayci O.; Kardas P.; Keil T.; Khaitov M.; Khaltaev N.; Kleine-Tebbe J.; Kouznetsov R.; Kowalski M.L.; Kritikos V.; Kull I.; La Grutta S.; Leonardini L.; Ljungberg H.; Lieberman P.; Lipworth B.; Lodrup Carlsen K.C.; Lopes-Pereira C.; Loureiro C.C.; Louis R.; Mair A.; Mahboub B.; Makris M.; Malva J.; Manning P.; Marshall G.D.; Masjedi M.R.; Maspero J.F.; Carreiro-Martins P.; Makela M.; Mathieu-Dupas E.; Maurer M.; De Manuel Keenoy E.; Melo-Gomes E.; Meltzer E.O.; Menditto E.; Mercier J.; Micheli Y.; Miculinic N.; Mihaltan F.; Milenkovic B.; Mitsias D.I.; Moda G.; Mogica-Martinez M.-D.; Mohammad Y.; Montefort S.; Monti R.; Morais-Almeida M.; Mösges R.; Münter L.; Muraro A.; Murray R.; Naclerio R.; Napoli L.; Namazova-Baranova L.; Neffen H.; Nekam K.; Neou A.; Nordlund B.; Novellino E.; Nyembue D.; O'Hehir R.; Ohta K.; Okubo K.; Onorato G.L.; Orlando V.; Ouedraogo S.; Palamarchuk J.; Pali-Schöll I.; Panzner P.; Park H.-S.; Passalacqua G.; Pépin J.-L.; Paulino E.; Pawankar R.; Phillips J.; Picard R.; Pinnock H.; Plavec D.; Popov T.A.; Portejoie F.; Price D.; Prokopakis E.P.; Psarros F.; Pugin B.; Puggioni F.; Quinones-Delgado P.; Raciborski F.; Rajabian-Söderlund R.; Regateiro F.S.; Reitsma S.; Rivero-Yeverino D.; Roberts G.; Roche N.; Rodriguez-Zagal E.; Roller-Wirnsberger R.E.; Rosario N.; Romano A.; Rottem M.; Ryan D.; Salimäki J.; Sanchez-Borges M.M.; Sastre J.; Scadding G.K.; Scheire S.; Schmid-Grendelmeier P.; Schünemann H.J.; Sarquis Serpa F.; Shamji M.; Sisul J.-C.; Solé D.; Somekh D.; Sooronbaev T.; Sova M.; Spertini F.; Spranger O.; Stellato C.; Stelmach R.; Thibaudon M.; To T.; Toumi M.; Usmani O.; Valero A.A.; Valenta R.; Valentin-Rostan M.; Pereira M.U.; van der Kleij R.; Van Eerd M.; Vandenplas O.; Vasankari T.; Vaz Carneiro A.; Vezzani G.; Viart F.; Viegi G.; Wallace D.; Wagenmann M.; Wang D.Y.; Waserman S.; Wickman M.; Williams D.M.; Wong G.; Wroczynski P.; Yiallouros P.K.; Yusuf O.M.; Zar H.J.; Zeng S.; Zernotti M.E.; Zhang L.; Shan Zhong N.; Zidarn M.
    Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed. © 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
  • No Thumbnail Available
    Item
    Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air® approach
    (John Wiley and Sons Inc, 2023) Bousquet J.; Anto J.M.; Sousa-Pinto B.; Czarlewski W.; Bedbrook A.; Haahtela T.; Klimek L.; Pfaar O.; Kuna P.; Kupczyk M.; Regateiro F.S.; Samolinski B.; Valiulis A.; Yorgancioglu A.; Arnavielhe S.; Basagaña X.; Bergmann K.C.; Bosnic-Anticevich S.; Brussino L.; Canonica G.W.; Cardona V.; Cecchi L.; Chaves-Loureiro C.; Costa E.; Cruz A.A.; Gemicioglu B.; Fokkens W.J.; Ivancevich J.C.; Kraxner H.; Kvedariene V.; Larenas-Linnemann D.E.; Laune D.; Louis R.; Makris M.; Maurer M.; Melén E.; Micheli Y.; Morais-Almeida M.; Mullol J.; Niedoszytko M.; Okamoto Y.; Papadopoulos N.G.; Patella V.; Pham-Thi N.; Rouadi P.W.; Sastre J.; Scichilone N.; Sheikh A.; Sofiev M.; Taborda-Barata L.; Toppila-Salmi S.; Tsiligianni I.; Valovirta E.; Ventura M.T.; Vieira R.J.; Zidarn M.; Amaral R.; Ansotegui I.J.; Bédard A.; Benveniste S.; Bewick M.; Bindslev-Jensen C.; Blain H.; Bonini M.; Bourret R.; Braido F.; Carreiro-Martins P.; Charpin D.; Cherrez-Ojeda I.; Chivato T.; Chu D.K.; Cingi C.; Del Giacco S.; de Blay F.; Devillier P.; De Vries G.; Doulaptsi M.; Doyen V.; Dray G.; Fontaine J.-F.; Gomez R.M.; Hagemann J.; Heffler E.; Hofmann M.; Jassem E.; Jutel M.; Keil T.; Kritikos V.; Kull I.; Kulus M.; Lourenço O.; Mathieu-Dupas E.; Menditto E.; Mösges R.; Murray R.; Nadif R.; Neffen H.; Nicola S.; O’Hehir R.; Olze H.; Palamarchuk Y.; Pépin J.-L.; Pétré B.; Picard R.; Pitsios C.; Puggioni F.; Quirce S.; Raciborski F.; Reitsma S.; Roche N.; Rodriguez-Gonzalez M.; Romantowski J.; Sá-Sousa A.; Serpa F.S.; Savouré M.; Shamji M.H.; Sova M.; Sperl A.; Stellato C.; Todo-Bom A.; Tomazic P.V.; Vandenplas O.; Van Eerd M.; Vasankari T.; Viart F.; Waserman S.; Fonseca J.A.; Zuberbier T.
    MASK-air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK-air® is a Good Practice of DG Santé on digitally-enabled, patient-centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co-operation and Development). MASK-air® data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK-air® data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as-needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom-medication score (ARIA-EAACI-CSMS) has been validated for clinical practice and trials. The implications of the novel MASK-air® results should lead to change management in rhinitis and asthma. © 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.